Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2019; 15(6):1177-1186. doi:10.7150/ijbs.33103 This issue Cite

Research Paper

PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23

Xiaole Wang1*, Jihua Guo1,2*, Xiaoxuan Che1, Rong Jia1✉

1. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, PR China.
2. Department of Endodontics, School & Hospital of Stomatology, Wuhan University, Wuhan, PR China.
*These authors contributed equally to this work.

✉ Corresponding author: Rong Jia, 237 Luoyu Road, Wuhan City, 430079, PR China. E-mail address: jiarongedu.cn Phone number: 86-27-87686268

Citation:
Wang X, Guo J, Che X, Jia R. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23. Int J Biol Sci 2019; 15(6):1177-1186. doi:10.7150/ijbs.33103. https://www.ijbs.com/v15p1177.htm
Other styles

File import instruction

Abstract

Graphic abstract

STAT3 plays very important roles in the initiation and development of tumors. Despite of extensive studies in repressing its activation and function via multiple ways, so far, there are few effective therapeutic methods to inhibit STAT3 in the clinic. STAT3 has two isoforms generated by alternative splicing of exon 23. STAT3α is the longer isoform and encodes the full-length oncogenic STAT3α protein. STAT3β is shorter and encodes the truncated and tumor-suppressive STAT3β protein. It remains unknown how the alternative splicing of STAT3 exon 23 is regulated. Here, we discovered that there is an exonic splicing suppressor (ESS) in exon 23. Importantly, splicing factor PCBP1 binds to this ESS. Overexpression of PCBP1 significantly reduced the proportion of STAT3α /STAT3β isoforms and the expression of STAT3α protein. Moreover, increased PCBP1 inhibited the growth of oral squamous cell carcinoma and breast cancer cells, and the expression of STAT3 target genes. Our results demonstrated that PCBP1 is the key splicing factor that promotes the switch from oncogenic isoform STAT3α to tumor-suppressive isoform STAT3β. Our results pave the way for finding new anti-STAT3 methods for cancer treatment.

Keywords: STAT3, Alternative splicing, Oncogene, head and neck cancer, PCBP1

Citation styles

APA
Wang, X., Guo, J., Che, X., Jia, R. (2019). PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23. International Journal of Biological Sciences, 15(6), 1177-1186. https://doi.org/10.7150/ijbs.33103.

ACS
Wang, X.; Guo, J.; Che, X.; Jia, R. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23. Int. J. Biol. Sci. 2019, 15 (6), 1177-1186. DOI: 10.7150/ijbs.33103.

NLM
Wang X, Guo J, Che X, Jia R. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23. Int J Biol Sci 2019; 15(6):1177-1186. doi:10.7150/ijbs.33103. https://www.ijbs.com/v15p1177.htm

CSE
Wang X, Guo J, Che X, Jia R. 2019. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23. Int J Biol Sci. 15(6):1177-1186.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use